Western diet enhances hepatic inflammation in mice exposed to cecal ligation and puncture

BMC Physiology

Volumn 10, Issue 1, 2010, Pages

  Rivera, Chantal A ^a   Gaskin, Latausha ^a   Singer, Georg ^a   Houghton, Jeff ^a   Allman, Monique ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; C57BL MOUSE; CECUM; DIET; DISEASE MODEL; HEPATITIS; HUMAN; IMMUNOLOGY; INFLAMMATION; LIGATION; LIVER; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; SEPSIS;

ANIMALS; CECUM; CHEMOKINE CCL2; DIET; DISEASE MODELS, ANIMAL; FATTY ACIDS; HEPATITIS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; LIGATION; LIVER; MALE; MICE; MICE, INBRED C57BL; SEPSIS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957903340     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-10-20     Document Type: Article

References (31)

1. The epidemiology of sepsis in the United States from 1979 through 2000. GS Martin DM Mannino S Eaton M Moss, N Engl J Med 2003 348 1546 1554 10.1056/NEJMoa022139 12700374
2. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. DC Angus WT Linde-Zwirble J Lidicker G Clermont J Carcillo MR Pinsky, Crit Care Med 2001 29 1303 1310 10.1097/00003246-200107000-00002 11445675
3. Classification, incidence, and outcomes of sepsis and multiple organ failure. JL Vincent F Taccone X Schmit, Contrib Nephrol 2007 156 64 74 full-text 17464116
4. Morbid obesity is an independent determinant of death among surgical critically ill patients. SA Nasraway Jr M Albert AM Donnelly R Ruthazer SA Shikora E Saltzman, Crit Care Med 2006 34 964 970 10.1097/01.CCM.0000205758. 18891.70 16484910
5. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. ME Akinnusi LA Pineda AA El Solh, Crit Care Med 2008 36 151 158 10.1097/01.CCM.0000297885.60037.6E 18007266
6. Obesity is associated with increased morbidity but not mortality in critically ill patients. Y Sakr C Madl D Filipescu R Moreno J Groeneveld A Artigas, et al. Intensive Care Med 2008 34 1999 2009 10.1007/s00134-008-1243-0 18670756
7. Walking, cycling, and obesity rates in Europe, North America, and Australia. DR Bassett Jr J Pucher R Buehler DL Thompson SE Crouter, J Phys Act Health 2008 5 795 814 19164816
8. Controlling obesity: what should be changed? G Varela-Moreiras, Int J Vitam Nutr Res 2006 76 262 268 10.1024/0300-9831.76.4.262 17243093
9. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. JY Lee J Ye Z Gao HS Youn WH Lee L Zhao, et al. J Biol Chem 2003 278 37041 37051 10.1074/jbc.M305213200 12865424
10. Arterial endothelial dysfunction in baboons fed a high-cholesterol, high-fat diet. Q Shi JF Vandeberg C Jett K Rice MM Leland L Talley, et al. Am J Clin Nutr 2005 82 751 759 16210703
11. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. JY Lee KH Sohn SH Rhee D Hwang, J Biol Chem 2001 276 16683 16689 10.1074/jbc.M011695200 11278967
12. Activation of NF-{kappa}B by Palmitate in Endothelial Cells: A Key Role for NADPH Oxidase-Derived Superoxide in Response to TLR4 Activation. E Maloney IR Sweet DM Hockenbery M Pham NO Rizzo S Tateya, et al. Arterioscler Thromb Vasc Biol 2009 29 1370 1375 10.1161/ATVBAHA.109.188813 19542021
13. TLR4 links innate immunity and fatty acid-induced insulin resistance. H Shi MV Kokoeva K Inouye I Tzameli H Yin JS Flier, J Clin Invest 2006 116 3015 3025 10.1172/JCI28898 17053832
14. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. CA Rivera P Adegboyega RN van Rooijen A Tagalicud M Allman M Wallace, J Hepatol 2007 47 571 579 10.1016/j.jhep.2007.04.019 17644211
15. Platelet Recruitment in the Murine Hepatic Microvasculature During Experimental Sepsis: Role of Neutrophils. Geor Singer Hide Urakami RD Specian KY Stokes DN Granger, Microcirc 2006 13 89 97 10.1080/10739680500466343 (Pubitemid 43216122)
16. Role of LPS in the hepatic microvascular dysfunction elicited by cecal ligation and puncture in mice. G Singer J Houghton CA Rivera C Anthoni DN Granger, J Hepatol 2007 47 799 806 10.1016/j.jhep.2007.07.021 17935822
17. Feeding a corn oil/sucrose-enriched diet enhances steatohepatitis in sedentary rats. CA Rivera SH Abrams MH Tcharmtchi M Allman TT Ziba MJ Finegold, et al. Am J Physiol Gastrointest Liver Physiol 2006 290 386 G393 10.1152/ajpgi.00229.2005 16223947
18. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. JY Lee A Plakidas WH Lee A Heikkinen P Chanmugam G Bray, et al. J Lipid Res 2003 44 479 486 10.1194/jlr.M200361-JLR200 12562875
19. Inflammatory and injury responses to ischemic stroke in obese mice. S Terao G Yilmaz KY Stokes M Ishikawa T Kawase DN Granger, Stroke 2008 39 943 950 10.1161/STROKEAHA.107.494542 18239178
20. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. AL Beal FB Cerra, JAMA 1994 271 226 233 10.1001/jama.271.3.226 8080494
21. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. DM Tsukumo MA Carvalho-Filho JB Carvalheira PO Prada SM Hirabara AA Schenka, et al. Diabetes 2007 56 1986 1998 10.2337/db06-1595 17519423
22. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. T Suganami K Tanimoto-Koyama J Nishida M Itoh X Yuan S Mizuarai, et al. Arterioscler Thromb Vasc Biol 2007 27 84 91 10.1161/01.ATV.0000251608. 09329.9a 17082484
23. Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4: roles for cd14, lps-binding protein, and md2 as targets for specificity of inhibition. C Erridge S Kennedy CM Spickett DJ Webb, J Biol Chem 2008 283 24748 24759 10.1074/jbc.M800352200 18559343
24. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. AE Medvedev KM Kopydlowski SN Vogel, J Immunol 2000 164 5564 5574 10820230
25. Impact of leukocytes and platelets in mediating hepatocyte apoptosis in a rat model of systemic endotoxemia. C Eipel R Bordel RM Nickels MD Menger B Vollmar, Am J Physiol Gastrointest Liver Physiol 2004 286 769 G776 10.1152/ajpgi.00275.2003 14715524
26. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. S Russwurm J Vickers A Meier-Hellmann P Spangenberg D Bredle K Reinhart, et al. Shock 2002 17 263 268 10.1097/00024382-200204000-00004 11954824
27. A platelet alpha granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. PE Stenberg RP McEver MA Shuman YV Jacques DF Bainton, J Cell Biol 1985 101 880 886 10.1083/jcb.101.3.880 2411738
28. Lipid modification of proteins and its relevance to protein targeting. AI Magee, J Cell Sci 1990 97 Pt 4 581 584 2077033
29. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. A Spruss G Kanuri S Wagnerberger S Haub SC Bischoff I Bergheim, Hepatol 2009 50 1094 1104 10.1002/hep.23122
30. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. S Thuy R Ladurner V Volynets S Wagner S Strahl A Konigsrainer, et al. J Nutr 2008 138 1452 1455 18641190
31. Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis *. [Article]. MM Tidswell WM Tillis SPM LaRosa MP Lynn AEM Wittek RM Kao, et al. Crit Care Med 2010 38 72 83 10.1097/CCM.0b013e3181b07b78 19661804